CME on ReachMD-logo

CME on ReachMD

ReachMD

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.
More Information

Location:

Fort Washington, PA

Networks:

ReachMD

Description:

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Language:

English


Episodes

When Insulin Isn’t Enough: Exploring Dual SGLT1 and SGLT2 Inhibition in T1DM

10/15/2018
More
CME credits: 0.50 Valid until: 14-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/when-insulin-isnt-enough-exploring-dual-sglt1-and-sglt2-inhibition-t1dm/10437/ This activity explores new and emerging treatments for type 1 diabetes, including a dual sodium glucose transporter 1/2 inhibitor, and provides both clinician and patient perspectives on their use.

Duration:00:19:29

Role of JAK-STAT Pathway in Rheumatoid Arthritis Disease Progression

10/1/2018
More
CME credits: 0.25 Valid until: 01-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/role-of-jak-stat-pathway-in-rheumatoid-arthritis-disease-progression/10404/ An ongoing mission in rheumatology is to better understand the complex mechanisms behind the inflammatory process responsible for the joint destruction in rheumatoid arthritis, or RA, to guide new treatment approaches. One such mediator called the JAK-STAT pathway has become an important therapeutic target because...

Duration:00:12:29

Opioid Use Disorder: Expanding Access to Treatment

9/28/2018
More
CME credits: 0.25 Valid until: 28-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/opioid-use-disorder-expanding-access-to-treatment/10410/ Opioid use disorder is a growing problem in the United States. Every day we hear about the rampant increase in the misuse of prescription analgesics, the easy accessibility of opioids, and the skyrocketing opioid overdoses that demonstrate the need for healthcare providers to not only understand more about these drugs, but also offer...

Duration:00:15:59

Rheumatoid Arthritis: Counseling Women Who Are Trying to Conceive

9/28/2018
More
CME credits: 0.25 Valid until: 28-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/rheumatoid-arthritis-counseling-women-who-are-trying-conceive/10403/ Rheumatoid arthritis, or RA, affects women three times more frequently than men, often in their childbearing years. Not only does pregnancy affect their disease course, healthcare needs and treatment options, but it also complicates the family planning decisions they are making. This makes the need for better support...

Duration:00:11:29

A Multi-Professional Approach to Driving Clear Results for Rosacea: A Case-Based Discussion

9/28/2018
More
CME credits: 0.50 Valid until: 12-10-2019 Claim your CME credit at https://reachmd.com/programs/cme/a-multi-professional-approach-to-driving-clear-results-for-rosacea-a-case-based-discussion/10384/ Rosacea is a common chronic disorder that affects as much as 10 percent of the population. This cutaneous disease is highly distressful to patients, as it can have ocular manifestations that come with a risk of vision loss. It is also associated with many comorbidities that are too often...

Duration:00:21:29

Precision Oncology: Incorporating Next Generation Sequencing (NGS) in NSCLC

9/28/2018
More
CME credits: 0.25 Valid until: 28-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/precision-oncology-incorporating-next-generation-sequencing-ngs-nsclc/10412/ Non-small cell lung cancer (NSCLC) is a leading cause of cancer death in the United States. Identification of targetable mutations has led to the development of therapies and improvements in NSCLC patient outcomes. However, many patients continue to experience poor survival due to suboptimal genomic profiling and...

Duration:00:14:59

Opioid Use Disorder: Expanding Access to Medication

9/28/2018
More
CME credits: 0.25 Valid until: 28-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/opioid-use-disorder-expanding-access-to-medication/10410/ Opioid use disorder is a growing problem in the United States. Every day we hear about the rampant increase in the misuse of prescription analgesics, the easy accessibility of opioids, and the skyrocketing opioid overdoses that demonstrate the need for healthcare providers to not only understand more about these drugs, but also offer...

Duration:00:15:59

Trading Places: The Future for MIS is in the Outpatient Setting…and the Future is Now!

9/27/2018
More
CME credits: 0.25 Valid until: 27-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/trading-places-future-mis-outpatient-setting-and-future-now/10411/ The ability to perform in-office minimally invasive procedures (MIS) has revolutionized the approach to abnormal uterine bleeding in women, giving them options for fast trauma-free assessment and management of their complaints. However, nearly 150 years after the first hysteroscopic procedure, MIS are still most commonly...

Duration:00:15:00

The P4 Approach: Predictive, Preventive, Personalized and Participatory Medicine

9/25/2018
More
CME credits: 1.00 Valid until: 25-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/the-p4-approach-predictive-preventive-personalized-and-participatory-medicine/10370/ Therapeutic options for the treatment of DR and DME have expanded, and advancements in medical imaging technologies provide a wider scope of options for efficient, accurate and reproducible diagnosis and monitoring of ocular conditions. Likewise, diabetes management guidelines and strategies, including...

Duration:00:53:29

Promising Bifunctional Agents in Immuno-Oncology: A Roundtable Discussion with the Experts

9/25/2018
More
CME credits: 0.25 Valid until: 25-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/promising-bifunctional-agents-in-immuno-oncology-a-roundtable-discussion-with-the-experts/10165/ The presence of transforming growth factor-beta (TGF-β) in the tumor microenvironment plays a main role in limiting the clinical efficacy of anti-PD-1/PD-L1 checkpoint inhibitors. Not only does TGF-β suppress the normal anti-tumor action of natural killer cells and T cells, but it is also...

Duration:00:16:00

Moving Toward A New Standard of Care: Checkpoint Inhibitors in Advanced Urothelial Cancer

9/25/2018
More
CME credits: 0.50 Valid until: 24-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/moving-toward-a-new-standard-of-care-checkpoint-inhibitors-in-advanced-urothelial-cancer/10347/ Urothelial cancer of the bladder, renal pelvis, ureter, and other urinary organs is the fifth most common cancer in the United States, and systemic platinum-based chemotherapy remains the standard of care for first-line treatment of advanced/metastatic urothelial carcinoma (UC). Until recently,...

Duration:00:22:30

Advances in Preterm Birth Prevention: Subcutaneous vs. Intramuscular Dosing of 17alpha-hydroxyprogesterone caproate – Pharmacokinetic Profile, Patient and Practitioner Impact

9/14/2018
More
CME credits: 0.25 Valid until: 14-09-2019 Claim your CME credit at https://reachmd.com/programs/cme/advances-preterm-birth-prevention-subcutaneous-intramuscular-dosing-17alpha-hydroxyprogesterone-capr/10385/ In light of the availability of a subcutaneously administered 17-OHPC, this activity will discuss strategies for providing optimal clinical management to women at risk for PTB, based on the SMFM, ACOG, and ACNM recommendations, as well as provide information surrounding the...

Duration:00:14:59

The Role of Allergy Testing to Achieve Personalized Treatment Goals for Allergic Rhinitis and Asthma

8/27/2018
More
CME credits: 0.25 Valid until: 27-08-2020 Claim your CME credit at https://reachmd.com/programs/cme/role-allergy-testing-achieve-personalized-treatment-goals-allergic-rhinitis-and-asthma/10351/ Allergic rhinitis (AR) and asthma are common allergic respiratory conditions. In fact, AR is a major factor in the development of asthma. Medical costs associated with these two conditions are high, but can be reduced considerably when following evidence-based diagnosis and treatment guidelines,...

Duration:00:13:59

Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate

8/13/2018
More
CME credits: 0.50 Valid until: 13-08-2019 Claim your CME credit at https://reachmd.com/programs/cme/clostridium-difficile-infection-applying-new-treatment-guidelines-strategies-reduce-recurrence-rate/10339/ Clostridium difficile infection (CDI) is the leading cause of infectious nosocomial diarrhea in developed countries. Approximately 25% of patients treated for this opportunistic infection experience recurrent or recalcitrant disease, and up to 40% of those patients develop an...

Duration:00:27:59

Raising Expectations for Rosacea: Best Practices That Drive Clear Results

8/10/2018
More
CME credits: 0.50 Valid until: 10-08-2019 Claim your CME credit at https://reachmd.com/programs/cme/raising-expectations-rosacea-best-practices-drive-clear-results/10340/ After encountering rosacea in clinical practice on a regular basis, it can become a force of habit to focus only on the cutaneous manifestations of the disease; however, the pathophysiological changes and comorbidities that make management much more complex are often overlooked. In this activity, Dr. J. Mark Jackson will...

Duration:00:20:59

What is the Role for TKIs in RCC? Highlights from the 18th Annual Meeting of the SUO

8/2/2018
More
CME credits: 0.75 Valid until: 02-08-2019 Claim your CME credit at https://reachmd.com/cme/project-oncology-cme/what-is-the-role-for-tkis-in-rcc-highlights-from-the-18th-annual-meeting-of-the-suo/9994/ Jointly provided by and Although renal cell carcinoma (RCC) accounts for only 2% to 3% of all adult cancers, for those who present with or progress to advanced RCC, the 5-year survival rate has never been above 10%. Several tyrosine-kinase inhibitors (TKIs), along with many other therapies,...

Duration:00:29:59

A New Innovation in the Prevention of Birth Prior to 37 Weeks Gestation

7/31/2018
More
CME credits: 0.25 Valid until: 31-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/a-new-innovation-in-the-prevention-of-birth-prior-to-37-weeks-gestation/10319/ In light of the availability of a subcutaneously administered 17-OHPC, this activity will discuss strategies for providing optimal clinical management to women at risk for PTB, based on the SMFM, ACOG, and ACNM recommendations. In addition, it will provide information surrounding the pharmacokinetic principles...

Duration:00:15:00

Multiple Sclerosis in Pediatric & Pregnant Patients: Challenges in Treatment

7/31/2018
More
CME credits: 0.25 Valid until: 31-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/multiple-sclerosis-pediatric-pregnant-patients-challenges-treatment/10334/ MS is a challenging chronic disease to manage for any healthcare professional, but the most difficult cases we often face involve children and pregnant women. Up to 5% of people diagnosed with MS are under the age of 16. The peak age of diagnosis for women falls between 20 and 50 years old; however, that also happens...

Duration:00:13:59

Advances in Preterm Birth Prevention: Subcutaneous vs. Intramuscular Dosing of 17-OHPC – Pharmacokinetic Profile, Patient and Practitioner Impact

7/31/2018
More
CME credits: 0.25 Valid until: 31-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/advances-preterm-birth-prevention-subcutaneous-intramuscular-dosing-17-ohpc/10319/ In light of the availability of a subcutaneously administered 17-OHPC, this activity will discuss strategies for providing optimal clinical management to women at risk for PTB, based on the SMFM, ACOG, and ACNM recommendations. In addition, it will provide information surrounding the pharmacokinetic...

Duration:00:15:00

Role of Fetal Fibronectin (fFN) in the Risk-Assessment for Preterm Birth (PTB)

7/30/2018
More
CME credits: 0.25 Valid until: 30-07-2019 Claim your CME credit at https://reachmd.com/programs/cme/role-fetal-fibronectin-ffn-risk-assessment-preterm-birth-ptb/10258/ About 30% of preterm labor spontaneously resolves and 50% of patients hospitalized for preterm labor actually give birth at term. Clinicians are left with the task to effectively assess women who are at risk for prenatal delivery in order to prevent preterm labor and reduce perinatal morbidity and mortality. In this...

Duration:00:12:59